乳腺癌的易感基因。 - Suppr

Suppr

超能文献

Susceptibility genes for breast cancer.

作者信息

Weber B L

机构信息

University of Pennsylvania Medical Center, Philadelphia 19104-6306.

出版信息

N Engl J Med. 1994 Dec 1;331(22):1523-4. doi: 10.1056/NEJM199412013312214.

DOI:10.1056/NEJM199412013312214

PMID:7969307

Abstract

摘要

相似文献

Susceptibility genes for breast cancer.乳腺癌的易感基因。

N Engl J Med. 1994 Dec 1;331(22):1523-4. doi: 10.1056/NEJM199412013312214.

[Susceptibility genes of familial breast cancer in Finland].[芬兰家族性乳腺癌的易感基因]

Duodecim. 1999;115(21):2365-74.

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.家族性前列腺癌中乳腺癌易感基因BRCA1和BRCA2的种系突变频率。癌症研究运动/英国前列腺癌研究组英国家族性前列腺癌研究协作组。

Cancer Res. 2000 Aug 15;60(16):4513-8.

Breast cancer susceptibility genes.乳腺癌易感基因

N Z Med J. 1996 Sep 13;109(1029):327-8.

Breast cancer genetics: what we know and what we need.乳腺癌遗传学：我们所知道的和我们所需要的。

Nat Med. 2001 May;7(5):552-6. doi: 10.1038/87876.

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.BRCA1/2 基因突变携带者以及乳腺癌和卵巢癌高危女性的预防与治疗。

Eur J Cancer Prev. 2000 Jun;9(3):139-50.

Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.对32个西班牙乳腺癌和/或卵巢癌家族的BRCA1和BRCA2基因进行分子分析。

Br J Cancer. 2000 Apr;82(7):1266-70. doi: 10.1054/bjoc.1999.1089.

The glittering prize.

Nat Genet. 1994 Oct;8(2):105-6. doi: 10.1038/ng1094-105.

Germ-line HER-2 variant and breast cancer risk by stage of disease.生殖系HER-2变异与不同疾病阶段的乳腺癌风险

Cancer Res. 2001 Dec 1;61(23):8393-4.

[Risk assessment for familial occurrence of breast cancer].[乳腺癌家族性发病的风险评估]

Zentralbl Gynakol. 1995;117(8):423-34.

引用本文的文献

Management of women at increased risk for breast cancer: preliminary results from a new program.乳腺癌高危女性的管理：一项新计划的初步结果

CMAJ. 1997 Nov 1;157(9):1235-42.

The economic appropriateness of laboratory tests.实验室检查的经济合理性。

J R Soc Med. 1997 Mar;90(3):151-4. doi: 10.1177/014107689709000309.

Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.头颈部肿瘤发生过程中 field cancerization 和多步骤进程的分子与细胞生物标志物。

Cancer Metastasis Rev. 1996 Mar;15(1):53-76. doi: 10.1007/BF00049487.

A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.关于遗传性乳腺癌、卵巢癌和结肠癌基因检测与咨询的社会行为学视角

CMAJ. 1996 Feb 15;154(4):457-64.

From disease surveillance to the surveillance of risk factors.从疾病监测到风险因素监测。

Am J Public Health. 1996 May;86(5):625-7. doi: 10.2105/ajph.86.5.625.

The future of breast and ovarian cancer clinics.乳腺癌和卵巢癌诊所的未来。

BMJ. 1995 Dec 16;311(7020):1584-5. doi: 10.1136/bmj.311.7020.1584.

Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.在10个乳腺癌/卵巢癌家族中检测到8种BRCA1突变，其中包括1个患有男性乳腺癌的家族。

Am J Hum Genet. 1995 Jul;57(1):1-7.

Progress against cancer.抗癌进展。

J Cancer Res Clin Oncol. 1995;121(11):633-47. doi: 10.1007/BF01218521.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验